HIV Breakthrough as New Injection 89% More Effective Than PrEP
"PrEP reduces the risk of getting HIV from sex by about 99 percent when taken as prescribed. Although there is less information about how effective PrEP pills are among people who inject drugs, we know that PrEP pills reduce the risk of getting HIV by at least 74 percent when taken as prescribed," the CDC says.
Twice-Yearly Injection 96% Effective in Preventing HIV Infection
A twice-yearly injection of Sunlenca (lenacapavir) reduces the risk of HIV infection by 96%, which is significantly more effective than oral pre-exposure prophylaxis (PrEP) using pills like Truvada, researchers report in the New England Journal of Medicine.
'Huge relief' as new drug found to effectively prevent HIV infection
A vaccination with the drug lenacapavir offers an effective protection against a HIV infection, according to newly published research from the pivotal phase-three study "Purpose 2". The option to vaccinate against HIV only every six months is a genuine breakthrough,
Gilead’s twice-yearly lenacapavir shows promise in HIV prevention trial
The Phase III Purpose 2 trial compared the safety and efficacy of twice-yearly subcutaneous lenacapavir for pre-exposure prophylaxis (PrEP) against once-daily oral Truvada.
Twice-Yearly Injection Reduces Risk of HIV Infection by 96%
For oral medications that prevent new HIV infection to be effective, the patient must take certain actions, including attending doctor's visits every three months and—most importantly—cons
TAG24 NEWS on MSN2d
Report confirms fewest new HIV cases since late 1980s – but experts warn decline is too slow
Fewer people contracted HIV last year than at any point since the rise of the disease in the late 1980s, the United Nations ...
PrEP therapies utter new hope in HIV preventive landscape as vaccine failures amass
The HIV vaccine space has seen dwindling research activity as drug manufacturers turn to PrEP therapies for preventive ...
HIV prevention pills should be free, but insurers are still charging
Insurance companies have to pay for PrEP under federal rules, but some skirt the requirement for free access to the treatment ...
Unlocking the Power of Community Advocacy to Help End the HIV Epidemic in Latine Communities
The Tampa Bay Times e-Newspaper is a digital replica of the printed paper seven days a week that is available to read on ...
The New Republic on MSN2dOpinion
Big Pharma Is the Only Reason Anyone Still Dies From HIV
While antiviral drugs to treat HIV had been approved a decade earlier, only five out of 33 million people who carried the ...
Kenya approves roll out of vaginal ring to protect women from HIV
Kenya’s ministry of health has approved the nationwide roll out of a vaginal ring to help women protect themselves from HIV.
Africa's making progress against HIV, but donor funds are drying up—what must change
Remarkable progress has been made against the HIV epidemic in the last two decades. However, a loss of momentum in fighting ...
Mother to child HIV transmission continues to be major concern in India
While India has made a significant effort in combating HIV/AIDS, the rate of vertical transmission, which happens from mother ...
How Gilead Is Driving Global Health Equity And Innovation
Dan O’Day drives Gilead's mission to end HIV worldwide, pioneering treatments like lenacapavir and championing global health ...
The Kenya Times on MSN3d
Bill Gates Opens Up on Finding Lifetime HIV Vaccine
U.S. philanthropist and entrepreneur Bill Gates has opened up about the search for a lifetime HIV vaccine, rather than one ...